Effects of glucose-insulin-potassium solution on acute myocardial infarction outcome in patients received streptokinase according to Killip classes.
Soltani
Zeynab
Z
Department of Cardiology, Tabriz University (Medical Sciences), Tabriz, Eastern Azerbaijan, Iran.
Samadikhah
Jahanbakhsh
J
Azarfarin
Rasoul
R
Hashemi
Bahram
B
Nezami
Nariman
N
D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D005947:Glucose / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000145:classification* / Q000188:drug therapy* / Q000401:mortality; D011188:Potassium / Q000627:therapeutic use; D016037:Single-Blind Method; D013300:Streptokinase / Q000627:therapeutic use*
D002314:Cardioplegic Solutions; D005343:Fibrinolytic Agents; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D013300:Streptokinase; D005947:Glucose; D011188:Potassium